ACHIEVE LIFE SCIENCES, INC. 4

Insider Martin Christopher Nathan received a compensatory grant of 25,000 stock options at $6.18 and 16,700 RSUs of Achieve Life Sciences, Inc. common stock on 2026-07-27.

On July 27, 2026, reporting person Martin Christopher Nathan, an insider of Achieve Life Sciences, Inc., received a grant of stock options to purchase 25,000 shares of common stock at an exercise price of $6.18 per share, vesting 100% on the earlier of July 27, 2027 or the date immediately prior to the issuer’s 2027 annual stockholders meeting, contingent on continued service. On the same date, he was also granted 16,700 restricted stock units, each representing a right to receive one share of common stock with identical vesting conditions. Both awards are new compensatory grants reported as acquisitions, leaving him with direct beneficial ownership of 25,000 common shares underlying the options and 16,700 common shares underlying RSUs after these transactions; absent a current trading price, the value of both the transactions and post-transaction holdings cannot be reliably estimated from the filing alone.

Filing Facts

CIK

949858

Ticker

ACHV

Form

4

Source Type

fda

Accession

0001193125-26-324256

Alert Tier

5